CHChang-Zern Hong

Chang-Zern Hong

*This is an algorithmically generated author record based on publicly available information.

Chang-Zern Hong has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Needling therapy for myofascial pain: recommended technique with multiple rapid needle insertion

    by Li-Wei Chou, Yueh-Ling Hsieh, Ta-Shen Kuan, Chang-Zern Hong

    Myofascial trigger point (MTrP) is a major cause of muscle pain, characterized with a hyperirritable spot due to accumulation of sensitized nociceptors in skeletal muscle fibers. Many needling therapy techniques for MTrP inactivation exist. Based on prior human and animal studies, multiple insertions can almost completely eliminate the MTrP pain forthwith. It is an attempt to stimulate many sensitive loci (nociceptors) in the MTrP region to induce sharp pain, referred pain or local twitch response. Suggested mechanisms of needling analgesia include effects related to immune, hormonal or nervous system. Compared to slow-acting biochemical effects involving immune or hormonal system, neurological effects can act faster to provide immediate and complete pain relief. Most likely mechanism of multiple needle insertion therapy for MTrP inactivation is to encounter sensitive nociceptors with the high-pressure stimulation of a sharp needle tip to activate a descending pain inhibitory system. This technique is strongly recommended for myofasical pain therapy in order to resume patient’s normal life rapidly, thus saving medical and social resources.


  • Low‐level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury: Possible involvements in hypoxia‐inducible factor 1α (HIF‐1α)

    by Yueh‐Ling Hsieh, Li‐Wei Chou, Pei‐Lin Chang, Chen‐Chia Yang, Mu‐Jung Kao, Chang‐Zern Hong

    Nerve inflammation plays an important role in the development and progression of neuropathic pain after chronic constrictive injury (CCI). Recent studies have indicated that hypoxia‐inducible factor 1α (HIF‐1α) is crucial in inflammation. Low‐level laser therapy has been used in treating musculoskeletal pain, but rare data directly support its use for neuropathic pain. We investigated the effects of low‐level laser on the accumulation of HIF‐1α, tumor necrosis factor‐α (TNF‐α), and interleukin‐1β (IL‐1β) in controlling neuropathic pain, as well as on the activation of vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) in promoting functional recovery in a rat CCI model. CCI was induced by placing four loose ligatures around the sciatic nerve of rats. Treatments of low‐level laser (660 nm, 9 J/cm2) or sham irradiation (0 J/cm2) were performed at the CCI sites for 7 consecutive days. The effects of laser in animals with CCI were determined by measuring the mechanical paw withdrawal threshold, as well as the sciatic, tibial, and peroneal function indices. Histopathological and immunoassay analyses were also performed. Low‐level laser therapy significantly improved paw withdrawal threshold and the sciatic, tibial, and peroneal functional indices after CCI. The therapy also significantly reduced the overexpressions of HIF‐1α, TNF‐α, and IL‐1β, and increased the amounts of VEGF, NGF, and S100 proteins. In conclusion, a low‐level laser could modulate HIF‐1α activity. Moreover, it may also be used as a novel and clinically applicable therapeutic approach for the improvement of tissue hypoxia/ischemia and inflammation in nerve entrapment neuropathy, as well as for the promotion of nerve regeneration. These findings might lead to a sufficient morphological and functional recovery of the peripheral nerve. J. Comp. Neurol. 520:2903–2916, 2012.


  • Open Access

    Mechanical pain sensitivity of deep tissues in children - possible development of myofascial trigger points in children

    by Ting-I Han, Chang-Zern Hong, Fang-Chuan Kuo, Yueh-Ling Hsieh, Li-Wei Chou, Mu-Jung Kao

    Background: It is still unclear when latent myofascial trigger points (MTrPs) develop during early life. This study is designed to investigate the mechanical pain sensitivity of deep tissues in children in order to see the possible timing of the development of latent MTrPs and attachment trigger points (A-TrPs) in school children. Methods: Five hundreds and five healthy school children (age 4- 11 years) were investigated. A pressure algometer was used to measure the pressure pain threshold (PPT) at three different sites in the brachioradialis muscle: the lateral epicondyle at elbow (site A, assumed to be the A-TrP site), the mid-point of the muscle belly (site B, assumed to be the MTrP site), and the muscle-tendon junction as a control site (site C). Results: The results showed that, for all children in this study, the mean PPT values was significantly lower (p < 0.05) at the assumed A-TrP site (site A) than at the other two sites, and was significantly lower (p < 0.05) at the assumed MTrP site (site B) than at the control site (site C). These findings are consistent if the data is analyzed for different genders, different dominant sides, and different activity levels. Conclusions: It is concluded that a child had increased sensitivity at the tendon attachment site and the muscle belly (endplate zone) after age of 4 years. Therefore, it is likely that a child may develop an A-Trp and a latent MTrP at the brachioradialis muscle after the age of 4 years. The changes in sensitivity, or the development for these trigger points, may not be related to the activity level of children aged 7-11 years. Further investigation is still required to indentify the exact timing of the initial occurrence of a-Trps and latent MTrPs.


  • A New Technique for Acupuncture Therapy and Its Effectiveness in Treating Fibromyalgia Syndrome: A Case Report

    by Li-Wei Chou, Judith Y. Hong, Chang-Zern Hong

    Background: The purpose of this case report is to demonstrate a new acupuncture technique in treating fibromyalgia syndrome [FMS]. Findings: A patient with FMS had poor responses to previous treatments. She received treatment at our acupuncture clinic. The new acupuncture technique we applied was similar to Hong's technique for myofascial trigger point injection but used simultaneous needle rotation to facilitate the insertion movement of a small acupuncture needle. After five sessions, she assessed her overall pain level to be at less than 20 percent of its original level. A follow-up confirmed that she was no longer suffering any serious discomfort. Conclusion: A patient with FMS may show remarkable pain relief after this treatment. The mechanism is probably similar to hyperstimulation analgesia, but postneedling discomfort may be reduced due to the small size of acupuncture needle. It is suggested to have a well-controlled, double-blinded study on a large sample to confirm that conclusion.


  • Treatment of myofascial pain syndrome

    by Chang-Zern Hong

    Myofascial pain syndrome (MPS) is caused by myofascial trigger points (MTrPs) located within taut bands of skeletal muscle fibers. Treating the underlying etiologic lesion responsible for MTrP activation is the most important strategy in MPS therapy. If the underlying pathology is not given the appropriate treatment, the MTrP cannot be completely and permanently inactivated. Treatment of active MTrPs may be necessary in situations in which active MTrPs persist even after the underlying etiologic lesion has been treated appropriately. When treating the active MTrPs or their underlying pathology, conservative treatment should be given before aggressive therapy. Effective MTrP therapies include manual therapies, physical therapy modalities, dry needling, or MTrP injection. It is also important to eliminate any perpetuating factors and provide adequate education and home programs to patients so that recurrent or chronic pain can be avoided.